Search results for “antibodies”

#Antibodies

#Northamerica

Andrew Bradbury is Chief Scientific Officer of Specifica, a company he founded in 2016, after retiring as Group Leader at LANL.

#gpcr #antibodies #ionchannels #drugdiscovery #proteinengineering

#Europe

Aneesh Vellatt Co-founder and Chief Scientific Officer at Maxion Therapeutics

#antibodies #drugdiscovery

#Europe

Caroline is CEO and co-founder of Elasmogen, a company that discovers and develops soloMER biologics for the treatment of inflammatory diseases and cancer.

#antibodies #proteincharacterization

#NorthAmerica

Scientist with a demonstrated history of working in the biotechnology industry. Skilled in Molecular Biology, Protein Biochemistry, and Antibody Engineering. Strong research professional with a Doctor

#antibodies #assaydevelopment

#NorthAmerica

Christine is currently working as a Principal Investigator, Biology at Arcus Biosciences

#proteins #antibodies #biology

#NorthAmerica

David Cipolla joined Insmed as VP of Research in 2018, where he is part of a team developing novel, targeted therapies to help serve the critical unmet needs of patients battling serious rare diseases

#antibodies #randd #anti-drugantibodies

#Europe

Thank you to the organizers for giving me the opportunity to present the validation of humanized transgenic mouse model to screen novel FC engineered monoclonal, but also multi specific antibodies.

#biotherapeutics #antibodies

#Northamerica

Ercole Rao is currently working as Group Leader Biologics Research - Engineered Protein Therapeutics at
Sanofi.

#oncology #drugdevelopment #antibodies

#NorthAmerica

Dr. Adams has over 18 years of experience in oncology biomarker/translational research, of which the last eight were dedicated to pharmaceutical drug development as a translational medicine lead.

#Optimization #Antibodies #therapeutics

#UnitedStates

Dr. Pediaditakis is the Associate Director of Neuroscience at Alchemab Therapeutics, a biotech company developing novel products for patients with hard-to-treat diseases by harnessing the power of nat

#biotech #vaccine #medicine #antibodies #immunology

#NorthAmerica

Jake engineers immune medicines.

#Manufacturing #Production #Antibodies #Biopharmaceuticals #ProteinTherapeutics

#Europe

Karoline Bechtold-Peters is pharmacist and holds a Doctor’s degree from the University of Munich as well as a degree as “Fachapotheker” for Pharmaceutical Technology.